实验性JAK抑制剂:目前,当前和未来的移植与宿主疾病管理?
Haris Ali1, Salman Otoukesh1, M Abdullah Jamil2
1Department of Hematology and Hemopoietic Cell Transplantation, City of Hope, Duarte, CA , USA.
Expert opinion on investigational drugs
|March 11, 2026
概括
简氏激酶 (JAK) 抑制剂提供了一个有针对性的方法来管理移植后的移植与宿主疾病 (GVHD). 本综述探讨了它们的疗效,安全性和未来在GVHD治疗的精密医学中的作用.
科学领域:
- 血造细胞移植 血造细胞移植
- 免疫调节是一种免疫调节.
- 在瘤学瘤学.
背景情况:
- 移植与宿主疾病 (GVHD) 是全原造血细胞移植 (HCT) 的主要并发症,导致显著的非复发性死亡率.
- 目前的预防策略不足,大约50%的患者患有GVHD,需要新的治疗方法.
研究的目的:
- 审查在GVHD.中使用Janus激酶 (JAK) 抑制剂的机制基础.
- 总结选择性和非选择性JAK抑制剂的临床前和临床证据.
- 分析GVHD预防的进展,生物标志物策略和目前FDA批准的治疗方法.
主要方法:
- 对治疗GVHD的JAK抑制剂进行临床前研究和临床试验数据的审查.
- 评估各种JAK抑制剂 (鲁克索利提尼布,巴里西提尼布,伊塔西提尼布,帕克里提尼布,罗瓦迪基提尼布) 的疗效和安全性.
- 分析最近在移植前预防和生物标志物驱动的方法的发展.
主要成果:
- 雅克抑制剂在GVHD中调节免疫反应方面显示出有前途的机理性理由.
- 临床数据突出显示了特定的JAK抑制剂在治疗GVHD中的有效性和安全性.
- 最近的进展包括改进的移植前策略和潜在生物标志物的识别.
结论:
- 治理GVHD正在向精确医学发展,远离广泛的免疫抑制.
- 预计将从"类固醇优先"方法转向风险分层算法,包括生物标志物分析和组合疗法.
- 高选择性JAK抑制剂和改进的获取是将其确立为GVHD的前线护理标准的关键.
相关概念视频
01:40Cell-mediated Immune Responses
85.7K
Overview
85.7K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
631
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
631
01:24Tissue Transplantation
1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K
01:22Bone Marrow Sampling and Transplants
2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
692
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
692